Overview

PREvention of VENous ThromboEmbolism Following Radical Prostatectomy

Status:
Terminated
Trial end date:
2019-11-01
Target enrollment:
Participant gender:
Summary
The PREVENTER Trial aims to compare the use of perioperative pharmacologic prophylaxis (subcutaneous heparin) with intermittent pneumatic compression devices (IPCs) to the use of IPCs alone for the prevention of venous thromboembolism (VTE) after radical prostatectomy (RP).
Phase:
Phase 4
Details
Lead Sponsor:
Johns Hopkins University
Treatments:
Calcium heparin
Heparin